Literature DB >> 23357529

Expression of p27Kip1, a cell cycle repressor protein, is inversely associated with potential carcinogenic risk in the genetic rodent models of obesity and long-lived Ames dwarf mice.

Isao Eto1.   

Abstract

INTRODUCTION: The association of genetic rodent models of obesity and cancer still remains a controversial issue. Although this controversy has largely been resolved in recent years for homozygous leptin receptor-deficient obese Zucker rats and homozygous long-lived Ames dwarf mice, it is still unresolved for homozygous leptin-deficient obese ob/ob mice.
OBJECTIVE: The objective of the present study described below was to investigate whether the expression of the cell cycle repressor protein p27(Kip1) is (a) down-regulated in the tumor-free homozygous leptin receptor-deficient obese Zucker rats as well as tumor-free homozygous leptin-deficient obese ob/ob mice and (b) up-regulated in the tumor-free homozygous long-lived Ames dwarf mice.
METHODS: To achieve this objective, we first performed western immunoblot analysis of the hepatic expression of p27. We then performed western immunoblot analysis and proteomic analysis of the hepatic expression of the proteins involved in the upstream molecular signaling pathways for the expression of p27. Lastly, we analyzed the serum levels of glucose, insulin, and branched-chain amino acids, all of which have been shown to regulate, causally and inversely, the expression of p27. RESULTS/
CONCLUSIONS: The results indicated that the hepatic expression of p27 was down-regulated in the homozygous leptin receptor-deficient obese Zucker rats and up-regulated in the homozygous long-lived Ames dwarf mice as expected. We also found that the hepatic expression of p27 was down-regulated in the homozygous leptin-deficient obese ob/ob mice. This last observation was not completely consistent with all of the results of the published studies where homozygous leptin-deficient obese ob/ob mice were used.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23357529      PMCID: PMC3970792          DOI: 10.1016/j.metabol.2013.01.001

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  33 in total

1.  Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100.

Authors:  X Li; S M Grundy; S B Patel
Journal:  J Lipid Res       Date:  1997-07       Impact factor: 5.922

2.  Obesity increases the incidence of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in an ovariectomized Zucker rat model.

Authors:  Reza Hakkak; Stewart MacLeod; Saeid Shaaf; Andy W Holley; Pippa Simpson; George Fuchs; Chan Hee Jo; Thomas Kieber-Emmons; Soheila Korourian
Journal:  Int J Oncol       Date:  2007-03       Impact factor: 5.650

3.  p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis.

Authors:  G Rodier; A Montagnoli; L Di Marcotullio; P Coulombe; G F Draetta; M Pagano; S Meloche
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

4.  Translational control of p27Kip1 accumulation during the cell cycle.

Authors:  L Hengst; S I Reed
Journal:  Science       Date:  1996-03-29       Impact factor: 47.728

Review 5.  Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.

Authors:  B Viollet; R Mounier; J Leclerc; A Yazigi; M Foretz; F Andreelli
Journal:  Diabetes Metab       Date:  2007-11-07       Impact factor: 6.041

6.  PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.

Authors:  Incheol Shin; F Michael Yakes; Federico Rojo; Nah-Young Shin; Andrei V Bakin; Jose Baselga; Carlos L Arteaga
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

7.  Upstream molecular signaling pathways of p27(Kip1) expression: effects of 4-hydroxytamoxifen, dexamethasone, and retinoic acids.

Authors:  Isao Eto
Journal:  Cancer Cell Int       Date:  2010-02-19       Impact factor: 5.722

8.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

Authors:  M Pagano; S W Tam; A M Theodoras; P Beer-Romero; G Del Sal; V Chau; P R Yew; G F Draetta; M Rolfe
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

9.  "Nutritional and chemopreventive anti-cancer agents up-regulate expression of p27Kip1, a cyclin-dependent kinase inhibitor, in mouse JB6 epidermal and human MCF7, MDA-MB-321 and AU565 breast cancer cells".

Authors:  Isao Eto
Journal:  Cancer Cell Int       Date:  2006-08-09       Impact factor: 5.722

Review 10.  Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer.

Authors:  Angel Alkarain; Joyce Slingerland
Journal:  Breast Cancer Res       Date:  2003-10-21       Impact factor: 6.466

View more
  2 in total

Review 1.  Reduced growth hormone signaling and methionine restriction: interventions that improve metabolic health and extend life span.

Authors:  Holly M Brown-Borg
Journal:  Ann N Y Acad Sci       Date:  2015-12-08       Impact factor: 5.691

Review 2.  Obesity and renal cancer: Role of adipokines in the tumor-immune system conflict.

Authors:  Asma Gati; Soumaya Kouidhi; Raja Marrakchi; Amel El Gaaied; Nadia Kourda; Amine Derouiche; Mohamed Chebil; Anne Caignard; Aurélie Perier
Journal:  Oncoimmunology       Date:  2014-01-16       Impact factor: 8.110

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.